Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Purine Antimetabolite [EPC]
Azathioprine is a potent purine antimetabolite immunosuppressant used to prevent kidney transplant rejection and treat severe rheumatoid arthritis. It works by inhibiting DNA synthesis in rapidly dividing immune cells.
Name
Azathioprine
Raw Name
AZATHIOPRINE
Category
Purine Antimetabolite [EPC]
Drug Count
4
Variant Count
32
Last Verified
February 17, 2026
RxCUI
359228, 105611, 197388, 359229, 404475, 404476, 199310, 239983
UNII
MRK240IY2L, AM94R510MS
About Azathioprine
Azathioprine is a potent purine antimetabolite immunosuppressant used to prevent kidney transplant rejection and treat severe rheumatoid arthritis. It works by inhibiting DNA synthesis in rapidly dividing immune cells.
Detailed information about Azathioprine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Azathioprine.
As a purine antimetabolite, Azathioprine works by interfering with the synthesis of purines (adenine and guanine), which are essential building blocks of DNA and RNA. By disrupting the production of genetic material, the drug prevents the rapid proliferation of cells, particularly T-lymphocytes and B-lymphocytes (white blood cells) that drive autoimmune attacks or organ rejection. Because it targets the very foundation of cell division, it is often referred to as a 'cytotoxic' or 'steroid-sparing' agent, allowing patients to reduce their reliance on long-term corticosteroid therapy, which often carries a higher burden of systemic side effects.
To understand how Azathioprine works, one must look at the molecular dance of DNA replication. Azathioprine itself is an inactive precursor. Once ingested, it is rapidly converted in the body—primarily in the liver and red blood cells—into its active metabolite, 6-mercaptopurine (6-MP). This conversion occurs through a non-enzymatic reaction with sulfhydryl compounds like glutathione.
Once 6-MP is formed, it enters the metabolic pathway of purines. The body's cells mistakenly use 6-MP as if it were a natural purine base. Through a series of enzymatic steps involving hypoxanthine-guanine phosphoribosyltransferase (HGPRT), 6-MP is converted into thioguanine nucleotides (TGNs). These TGNs are the 'molecular saboteurs' of the immune system. They incorporate themselves into the growing DNA strands of replicating cells. Because they are structural analogs (mimics) of natural bases, their presence causes the DNA strand to break or prevents further replication.
Furthermore, Azathioprine metabolites inhibit the de novo pathway of purine synthesis—the primary way lymphocytes create DNA. Unlike many other cells in the body that can 'recycle' purines through a salvage pathway, T and B cells are uniquely dependent on this de novo synthesis. This makes Azathioprine selectively toxic to the very immune cells responsible for inflammation and tissue rejection, while sparing many other cell types.
The pharmacokinetics of Azathioprine are complex and highly dependent on an individual's genetic makeup, particularly the activity of specific enzymes.
Azathioprine is FDA-approved for two primary indications, though its 'off-label' utility is vast:
Off-Label Uses: Healthcare providers frequently prescribe Azathioprine for Crohn's disease, ulcerative colitis, systemic lupus erythematosus (SLE), autoimmune hepatitis, and certain severe skin conditions like pemphigus vulgaris. These uses are supported by extensive clinical literature, even if not explicitly listed in the original FDA label.
Azathioprine is primarily available in the following formats:
> Important: Only your healthcare provider can determine if Azathioprine is right for your specific condition. Genetic testing for TPMT activity is strongly recommended before starting therapy to ensure safety.
Dosage of Azathioprine is highly individualized and is often calculated based on the patient's body weight and their specific medical condition. Healthcare providers aim to find the lowest effective dose to minimize the risk of toxicity.
Azathioprine is used in children, particularly for post-transplant care and autoimmune conditions like IBD or juvenile idiopathic arthritis. While the FDA label primarily focuses on adults for RA, pediatric dosing for transplant is similar to adult dosing on a mg/kg basis (3 to 5 mg/kg/day initially). Pediatric use requires extreme caution and frequent monitoring of blood counts by a specialist in pediatric immunology or nephrology.
Because the metabolites of Azathioprine are cleared by the kidneys, patients with impaired renal function (kidney disease) may require lower doses. Healthcare providers typically reduce the dose in patients with a low Glomerular Filtration Rate (GFR) to prevent the accumulation of toxic metabolites.
Since the liver is the primary site of Azathioprine metabolism, patients with liver disease must be monitored closely. Doses may need to be reduced if liver function tests (ALT/AST) become elevated.
Older adults are often started on the lower end of the dosing range. This is due to the higher frequency of decreased renal or hepatic function and the increased risk of infection or bone marrow suppression in the geriatric population.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Never double the dose to make up for a missed one, as this significantly increases the risk of bone marrow toxicity.
An overdose of Azathioprine is a medical emergency. Signs of overdose may include severe nausea, vomiting, diarrhea, unusual bruising or bleeding, and signs of infection (fever, sore throat). These symptoms are often delayed, appearing days or even weeks after the ingestion as the bone marrow's production of blood cells drops.
In case of suspected overdose, contact a Poison Control Center or seek emergency medical attention immediately. Treatment is generally supportive, as there is no specific antidote for Azathioprine poisoning.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as this could lead to organ rejection or a severe flare-up of your condition.
Most patients taking Azathioprine will experience some form of mild side effect, particularly during the first few weeks of treatment as the body adjusts.
> Warning: Stop taking Azathioprine and call your doctor immediately if you experience any of these symptoms.
Azathioprine is often taken for years, which introduces risks that are not present with short-term use.
The FDA has issued a Black Box Warning for Azathioprine regarding the risk of malignancy (cancer).
Physicians should inform patients of the risk of malignancy and monitor them for any signs of unusual growths, swollen lymph nodes, or unexplained weight loss.
Report any unusual symptoms to your healthcare provider immediately. Regular blood tests are mandatory while taking this medication.
Azathioprine is a high-alert medication. It requires careful management because the line between a therapeutic dose and a toxic dose can be narrow. Patients must be committed to regular laboratory monitoring and must report any signs of illness immediately. Because it suppresses the immune system, live vaccines (such as the MMR or Yellow Fever vaccine) should generally be avoided, as they could cause a full-blown infection.
Malignancy Risk: According to the FDA-approved labeling, patients receiving immunosuppressive agents, including Azathioprine, have an increased risk of developing lymphoma and other malignancies, notably of the skin. Physicians should monitor for the development of these conditions. A specific, rare form of cancer called Hepatosplenic T-cell Lymphoma has been reported, particularly in patients with IBD using Azathioprine in combination with TNF-alpha inhibitors.
Standard monitoring protocols for Azathioprine typically include:
Azathioprine generally does not affect the ability to drive or operate machinery. However, if you experience dizziness or extreme fatigue (which could be a sign of anemia), avoid these activities until you have consulted your doctor.
Alcohol should be used with extreme caution. Both Azathioprine and alcohol are processed by the liver. Combining them can increase the risk of liver strain or damage. Most healthcare providers recommend limiting alcohol intake significantly while on this medication.
Do not stop taking Azathioprine suddenly unless instructed by your doctor (e.g., in the case of a severe reaction). For patients with RA, stopping the drug can lead to a severe flare of joint pain and swelling. For transplant patients, stopping the drug can lead to immediate and irreversible organ rejection. If the drug must be stopped, it is usually done under close medical supervision.
> Important: Discuss all your medical conditions, especially any history of cancer, liver disease, or kidney disease, with your healthcare provider before starting Azathioprine.
Azathioprine does not typically interfere with the chemical analysis of lab tests, but it will change the results of blood tests (lowering WBC, increasing MCV) because of its pharmacological action. It may also cause a false-positive result in certain tests for uric acid.
For each major interaction, the mechanism usually involves the inhibition of metabolic enzymes (like XO or TPMT) or a synergistic effect on the bone marrow. The consequence is almost always an increased risk of life-threatening toxicity or a decrease in the drug's effectiveness.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter vitamins can sometimes affect how your body processes Azathioprine.
Azathioprine must NEVER be used in the following circumstances:
These are conditions where the drug may be used, but only with extreme caution and a careful risk-benefit analysis:
There is a high degree of cross-sensitivity between Azathioprine and its metabolite, 6-mercaptopurine. If you have had a 'drug fever' or a severe rash with one, you will almost certainly have it with the other. There is no known cross-sensitivity with other immunosuppressants like methotrexate or mycophenolate mofetil.
> Important: Your healthcare provider will evaluate your complete medical history, including genetic testing results, before prescribing Azathioprine.
Azathioprine is classified as FDA Pregnancy Category D. This means there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience. However, the potential benefits may warrant use of the drug in pregnant women in certain life-threatening situations (like organ transplant maintenance).
Azathioprine and its metabolite 6-MP are excreted in human breast milk in very low concentrations. While early guidelines recommended against breastfeeding, more recent data from the American College of Rheumatology (ACR) suggests that breastfeeding while taking Azathioprine is likely safe, as the amount the infant receives is negligible. Nonetheless, infants should be monitored for any signs of infection or low white blood cell counts.
Azathioprine is used in children for kidney transplant and off-label for IBD. The safety profile is generally similar to that in adults. However, long-term use in children raises concerns about the lifetime risk of developing malignancies. Growth should be monitored, although Azathioprine does not typically cause the growth suppression seen with long-term corticosteroid use.
Clinical studies did not include enough subjects aged 65 and over to determine if they respond differently than younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range. This reflects the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
In patients with renal insufficiency, the clearance of metabolites is reduced. The initial dose should be at the lower end of the range, and the patient must be monitored more frequently for signs of bone marrow toxicity. Hemodialysis removes some of the drug's metabolites, so dosing may need to be timed around dialysis sessions.
Patients with liver disease (Child-Pugh Class B or C) require careful monitoring. If Azathioprine-induced liver injury is suspected, the drug must be stopped immediately. In some cases, the injury is dose-dependent, while in others, it is an idiosyncratic (unpredictable) reaction.
> Important: Special populations require individualized medical assessment and frequent lab work to ensure safety.
Azathioprine is a prodrug of the purine analogue 6-mercaptopurine (6-MP). Its primary mechanism of action is the inhibition of DNA, RNA, and protein synthesis.
The onset of action for Azathioprine is slow. In rheumatoid arthritis, it may take 6 to 12 weeks to see a clinical benefit. In IBD, it can take up to 3 to 6 months. This is because the drug must build up sufficient levels of active metabolites within the cells to effectively suppress the immune response.
| Parameter | Value |
|---|---|
| Bioavailability | 47% - 60% |
| Protein Binding | ~30% |
| Half-life (Parent) | ~3 hours |
| Half-life (Active TGNs) | 1 - 2 weeks (intracellular) |
| Tmax | 1 - 2 hours |
| Metabolism | XO, TPMT, HGPRT |
| Excretion | Renal (>90% as metabolites) |
Azathioprine is a Purine Antimetabolite [EPC] and an Immunosuppressant. It is related to other antimetabolites like Methotrexate and Mycophenolate Mofetil, though its specific chemical structure and metabolic pathway are unique.
Medications containing this ingredient
Common questions about Azathioprine
Azathioprine is primarily used to prevent the body from rejecting a kidney transplant and to treat severe rheumatoid arthritis that hasn't responded to other medications. Beyond these FDA-approved uses, doctors often prescribe it for autoimmune conditions like Crohn's disease, ulcerative colitis, and lupus. It works as an immunosuppressant, meaning it dials down the immune system's overactive response. Because it is a potent drug, it is usually reserved for cases where other treatments have failed. It is often called a 'steroid-sparing' drug because it helps patients reduce their dose of prednisone or other steroids.
The most frequent side effects are nausea and vomiting, which affect about 10-15% of patients, especially when starting the medication. Many people also experience a drop in their white blood cell count, which increases the risk of catching infections like colds or the flu. Other common issues include loss of appetite and a general feeling of being unwell. To help with stomach upset, doctors often recommend taking the tablet with food or splitting the daily dose into two smaller ones. Most of these side effects are manageable with close medical supervision and dose adjustments.
It is generally advised to limit or avoid alcohol while taking Azathioprine. Both the medication and alcohol are processed by the liver, and combining them can significantly increase the risk of liver damage or 'hepatotoxicity.' Since Azathioprine already requires regular liver function tests to monitor for stress, adding alcohol makes it harder for your doctor to determine if the drug is causing harm. If you do choose to drink, it should be in very small amounts and only after discussing it with your healthcare provider. Always follow the specific advice of your specialist regarding alcohol consumption.
Azathioprine is generally considered a high-risk medication during pregnancy (Category D), but it is not strictly forbidden in all cases. In transplant patients, the risk of losing the transplanted organ if the drug is stopped is often greater than the risk to the fetus. However, for rheumatoid arthritis, it is usually avoided in favor of safer alternatives. Some studies have linked its use to premature birth and low birth weight. If you are planning to become pregnant, it is vital to have a detailed discussion with your rheumatologist or transplant team. They will weigh the risks of the drug against the risks of your condition flaring up during pregnancy.
Azathioprine is a slow-acting medication and does not provide immediate relief. For conditions like rheumatoid arthritis, it typically takes 6 to 12 weeks of consistent use before you notice a significant improvement in your symptoms. In cases of inflammatory bowel disease (Crohn's or colitis), it may take even longer—sometimes up to 3 to 6 months—to reach its full effect. Because of this delay, doctors often prescribe a faster-acting medication, like a corticosteroid, to control symptoms while waiting for the Azathioprine to start working. Patience and adherence to the daily schedule are key to the success of this treatment.
You should never stop taking Azathioprine suddenly without consulting your doctor first. For transplant patients, stopping the drug even for a few days can trigger an immune attack on the organ, leading to rejection and potential organ failure. For those with autoimmune diseases, a sudden stop can cause a 'rebound' effect where your symptoms return much worse than before. If the drug needs to be stopped due to side effects, your doctor will provide a specific plan to taper the dose or switch you to a different medication. Always keep a sufficient supply of your medication to avoid running out.
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular timing. Do not take two doses at once to make up for the one you missed, as this can increase the risk of toxic effects on your bone marrow. If you miss more than one dose in a row, it is a good idea to contact your doctor's office for advice. Consistency is very important for keeping your immune system stable, so using a pillbox or a phone alarm can be very helpful.
Azathioprine itself does not typically cause weight gain; in fact, it is more likely to cause a loss of appetite or nausea, which can lead to weight loss. However, many patients take Azathioprine alongside corticosteroids like prednisone, which are well-known for causing significant weight gain and increased appetite. If you notice weight gain while taking Azathioprine, it is likely due to other medications in your regimen or an improvement in your overall health that allows you to eat more comfortably. If weight changes are a concern, discuss your diet and medication list with your healthcare provider.
Azathioprine has several significant drug interactions that your doctor must monitor. The most dangerous interaction is with gout medications like allopurinol or febuxostat, which can cause Azathioprine levels to skyrocket to toxic levels. It can also interact with certain blood pressure medicines (ACE inhibitors) and blood thinners like warfarin. Because it suppresses the immune system, you should also avoid live vaccines while on this drug. Always provide your doctor and pharmacist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking to ensure your safety.
Yes, Azathioprine is widely available as a generic medication, which is typically much more affordable than the original brand-name version, Imuran. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name drug. Most insurance plans cover the generic version of Azathioprine. Because it is an older medication, the generic market is well-established, and you should be able to find it at almost any retail pharmacy. If you have concerns about switching between different generic manufacturers, speak with your pharmacist.